NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 272 filers reported holding NEOGENOMICS INC in Q1 2020. The put-call ratio across all filers is 1.09 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27,269 | -9.7% | 2,217 | +18.0% | 0.00% | 0.0% |
| Q2 2023 | $30,196 | -28.3% | 1,879 | -21.5% | 0.00% | -42.9% |
| Q1 2023 | $42,141 | -84.2% | 2,393 | -91.7% | 0.01% | -86.5% |
| Q4 2022 | $267,073 | +44.4% | 28,904 | +34.7% | 0.05% | +33.3% |
| Q3 2022 | $185,000 | +1.1% | 21,454 | -4.2% | 0.04% | 0.0% |
| Q2 2022 | $183,000 | -35.6% | 22,405 | +2.2% | 0.04% | -25.0% |
| Q1 2022 | $284,000 | -30.7% | 21,919 | +20.0% | 0.05% | -22.4% |
| Q4 2021 | $410,000 | -41.0% | 18,270 | +14.0% | 0.07% | -46.4% |
| Q3 2021 | $695,000 | 0.0% | 16,029 | 0.0% | 0.12% | 0.0% |
| Q2 2021 | $695,000 | -4.7% | 16,029 | +6.1% | 0.12% | -13.2% |
| Q1 2021 | $729,000 | -5.7% | 15,111 | +5.3% | 0.14% | -10.0% |
| Q4 2020 | $773,000 | +48.9% | 14,355 | +9.3% | 0.16% | +11.1% |
| Q3 2020 | $519,000 | -68.2% | 13,128 | -75.9% | 0.14% | +105.7% |
| Q1 2020 | $1,634,000 | – | 54,472 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 1,785,605 | $86,138,000 | 34.19% |
| PERKINS CAPITAL MANAGEMENT INC | 157,750 | $7,610,000 | 4.71% |
| Blue Water Life Science Advisors, LP | 222,222 | $10,719,000 | 3.49% |
| First Light Asset Management, LLC | 1,055,960 | $50,940,000 | 3.36% |
| Ranger Investment Management | 810,956 | $39,121,000 | 2.09% |
| Bullseye Asset Management LLC | 108,054 | $5,212,000 | 1.81% |
| Lombard Odier Asset Management (Switzerland) SA | 584,281 | $28,186,000 | 1.75% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 998,858 | $48,185,000 | 1.67% |
| EMERALD ADVISERS, LLC | 904,298 | $43,623,000 | 1.58% |
| Soleus Capital Management, L.P. | 190,556 | $9,192,000 | 1.43% |